Volcano Announces FDA 510(k) Clearance of Revolution Rotational Catheter and FFR for the s5i Integrated IV...( First ever imaging system that incor...)

First ever imaging system that incorporates phased Array IVUS, Rotational IVUS and integrated FFR all onto a single platform, providing Physicians

and Administrators Choice

SAN DIEGO, Feb. 7 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced today FDA 510(k) clearance of the s5-Revo and s5-FFR (fractional flow reserve) options. These two new product offerings now enable rotational IVUS and FFR to operate on the same integrated Volcano s5 Imaging System as Volcano's previous line of phased array IVUS catheters and functionality. For the first time, physicians can choose among three powerful diagnostic tools -- all on the same integrated IVUS platform.

Scott Huennekens, president and chief executive officer of Volcano, commented, "Volcano welcomes the addition of these two important technologies to the s5 family of consoles. By adding high resolution rotational IVUS and pressure-based FFR to our already highly successful phased array s5 imaging platform, we will be providing a level of technology, clinical utility and convenience that is un-matched in the intravascular imaging field. Physicians, nurses and administrators can now have fast, easy access to state-of-the-art therapy guiding technologies like IVUS and FFR. No other company currently provides a system that integrates this level of functionality and convenience in a single platform. Our message now is simple; Volcano offers all three technologies on one system, you the physician can now choose which technology is best for you, best for your staff, and best for your patient."

Earlier generation consoles included on
'/>"/>